Brief: InspireMD Says FDA Approval Triggers Second Warrant Tranche In $113.6 Million Financing
24/06/2025 21:19
June 24 (Reuters) - InspireMD Inc NSPR.O: INSPIREMD ANNOUNCES FDA APPROVAL FOR CGUARD® PRIME CAROTID STENT SYSTEM FOR THE PREVENTION OF STROKE INSPIREMD INC - FDA APPROVAL TRIGGERS SECOND WARRANT TRANCHE IN $113.6 MILLION FINANCING Source text: ID:nGNXbcLmcV Further company coverage: NSPR.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on InspireMD
See all newsInspireMD Inc reports results for the quarter ended June 30 - Earnings Summary
InspireMD Q2 revenue beats estimates on international demand
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Inc expected to post a loss of 20 cents a share - Earnings Preview
InspireMD Q1 revenue jumps 122%, beats estimates on product demand